Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement
Open Access
- 30 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 4 (2) , 120-125
Abstract
Post-operative atrial fibrillation (POAF) is a frequent complication after open-heart surgery, and cardioversions (CV) are commonly performed to restore sinus rhythm. However, little data exists on thrombo-embolic risk related to early post-operative CV and on the recurrence of POAF after CV. CAREAVR study sought to assess the rate of strokes, transient ischaemic attacks (TIA), and mortality shortly after POAF-triggered CV in patients who underwent isolated surgical aortic valve replacement (SAVR) with a bioprosthesis. Altogether 721 patients underwent isolated SAVR with a bioprosthesis at four Finnish university hospitals. During post-operative hospitalization, after patients with prior chronic AF were excluded, 309/634 (48.7%) of patients had at least one episode of POAF [median time (interquartile range) 3 (3) days], and an electrical CV was performed in 113/309 (36.6%) of them. The length of hospital stay was not affected by CV. At 30 days follow-up, the rate of stroke, TIA or mortality was higher in those AF patients who underwent CV vs. those who did not (9.7% vs. 3.6%, P = 0.04, respectively; adjusted hazard ratio 2.63, 95% confidence interval 1.00–6.92, P = 0.05). Similar proportion of patients in both groups were in AF rhythm at discharge (32.7% vs. 35.7%, P = 0.18); and at 3 months (25.0% vs. 23.6%, P = 0.40), respectively. In this real-world population of patients undergoing isolated SAVR, the rate of POAF was nearly 50%. One-third of these patients underwent an electrical CV, and they exhibited over two-fold risk for thromboembolisms and mortality. Cardioversion did not affect the short-term prevalence of AF.Keywords
Funding Information
- Finnish Medical Foundation
- Finnish Foundation for Cardiovascular Research
- Emil Aaltonen Foundation
- Maud Kuistila Foundation
This publication has 19 references indexed in Scilit:
- Low stroke risk after elective cardioversion of atrial fibrillation: An analysis of the Flec-SL trialInternational Journal of Cardiology, 2013
- Thromboembolic Complications After Cardioversion of Acute Atrial FibrillationJACC, 2013
- Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and RhythmJACC, 2013
- Dabigatran Versus Warfarin in Patients With Atrial FibrillationCirculation, 2011
- Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac SurgeryJACC, 2008
- Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial FibrillationCirculation, 2004
- Atrial Fibrillation Activates Platelets and Coagulation in a Time-Dependent Manner: A Study in Patients With Paroxysmal Atrial FibrillationJACC, 1997
- Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutterJACC, 1992
- Anticoagulation for cardioversion of atrial fibrillationThe American Journal of Cardiology, 1989
- The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillationThe American Journal of Cardiology, 1969